D-dimer and HbA1c levels findings in COVID-19 Iraqi patients
Abstract On March 11, 2020, the World Health Organization (WHO) declared a new coronavirus infection caused by the SARS-CoV-2 virus as a pandemic, making it the 11th pandemic of the 20th and 21st centuries. This study investigated the clinical and laboratory results (D-dimer, conventional coagulation, and HbA1c biomarker concentrations) of 150 patients (75 male and 75 female) with confirmed COVID-19 pneumonia and 50 controls (25 male and 25 female). For disease diagnosis, all COVID-19 patients were given a Real-Time Reverse Transcription Polymerase Chain Reaction Assay (RT-PCR). The findings revealed that D-dimer and HbA1c levels in COVID-19 patients were significantly higher (P 0.001) at the time of admission; In COVID-19 patients, there was also a strong correlation between D-dimer levels and HbA1c levels (P 0.001). In conclusion, COVID-19 patients are more likely to have a poor prognosis if their D-dimer and HbA1c levels remain uncontrolled over a lengthy period. To lower the likelihood of a bad prognosis in COVID-19, patients with higher levels of D-dimer and HbA1c should be continuously monitored.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Instituto Internacional de Ecologia
2024
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000100416 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
oai:scielo:S1519-69842024000100416 |
|---|---|
| record_format |
ojs |
| spelling |
oai:scielo:S1519-698420240001004162023-01-02D-dimer and HbA1c levels findings in COVID-19 Iraqi patientsAl-Jubury,K. S.K,O. AbdulmunemAlshareef,D. K. J.Al-Jubury,M.Jameel,M. I. COVID-19 D-dimer HbA1c RT-PCR Abstract On March 11, 2020, the World Health Organization (WHO) declared a new coronavirus infection caused by the SARS-CoV-2 virus as a pandemic, making it the 11th pandemic of the 20th and 21st centuries. This study investigated the clinical and laboratory results (D-dimer, conventional coagulation, and HbA1c biomarker concentrations) of 150 patients (75 male and 75 female) with confirmed COVID-19 pneumonia and 50 controls (25 male and 25 female). For disease diagnosis, all COVID-19 patients were given a Real-Time Reverse Transcription Polymerase Chain Reaction Assay (RT-PCR). The findings revealed that D-dimer and HbA1c levels in COVID-19 patients were significantly higher (P 0.001) at the time of admission; In COVID-19 patients, there was also a strong correlation between D-dimer levels and HbA1c levels (P 0.001). In conclusion, COVID-19 patients are more likely to have a poor prognosis if their D-dimer and HbA1c levels remain uncontrolled over a lengthy period. To lower the likelihood of a bad prognosis in COVID-19, patients with higher levels of D-dimer and HbA1c should be continuously monitored.info:eu-repo/semantics/openAccessInstituto Internacional de EcologiaBrazilian Journal of Biology v.84 20242024-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000100416en10.1590/1519-6984.266823 |
| institution |
SCIELO |
| collection |
OJS |
| country |
Brasil |
| countrycode |
BR |
| component |
Revista |
| access |
En linea |
| databasecode |
rev-scielo-br |
| tag |
revista |
| region |
America del Sur |
| libraryname |
SciELO |
| language |
English |
| format |
Digital |
| author |
Al-Jubury,K. S. K,O. Abdulmunem Alshareef,D. K. J. Al-Jubury,M. Jameel,M. I. |
| spellingShingle |
Al-Jubury,K. S. K,O. Abdulmunem Alshareef,D. K. J. Al-Jubury,M. Jameel,M. I. D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| author_facet |
Al-Jubury,K. S. K,O. Abdulmunem Alshareef,D. K. J. Al-Jubury,M. Jameel,M. I. |
| author_sort |
Al-Jubury,K. S. |
| title |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| title_short |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| title_full |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| title_fullStr |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| title_full_unstemmed |
D-dimer and HbA1c levels findings in COVID-19 Iraqi patients |
| title_sort |
d-dimer and hba1c levels findings in covid-19 iraqi patients |
| description |
Abstract On March 11, 2020, the World Health Organization (WHO) declared a new coronavirus infection caused by the SARS-CoV-2 virus as a pandemic, making it the 11th pandemic of the 20th and 21st centuries. This study investigated the clinical and laboratory results (D-dimer, conventional coagulation, and HbA1c biomarker concentrations) of 150 patients (75 male and 75 female) with confirmed COVID-19 pneumonia and 50 controls (25 male and 25 female). For disease diagnosis, all COVID-19 patients were given a Real-Time Reverse Transcription Polymerase Chain Reaction Assay (RT-PCR). The findings revealed that D-dimer and HbA1c levels in COVID-19 patients were significantly higher (P 0.001) at the time of admission; In COVID-19 patients, there was also a strong correlation between D-dimer levels and HbA1c levels (P 0.001). In conclusion, COVID-19 patients are more likely to have a poor prognosis if their D-dimer and HbA1c levels remain uncontrolled over a lengthy period. To lower the likelihood of a bad prognosis in COVID-19, patients with higher levels of D-dimer and HbA1c should be continuously monitored. |
| publisher |
Instituto Internacional de Ecologia |
| publishDate |
2024 |
| url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842024000100416 |
| work_keys_str_mv |
AT aljuburyks ddimerandhba1clevelsfindingsincovid19iraqipatients AT koabdulmunem ddimerandhba1clevelsfindingsincovid19iraqipatients AT alshareefdkj ddimerandhba1clevelsfindingsincovid19iraqipatients AT aljuburym ddimerandhba1clevelsfindingsincovid19iraqipatients AT jameelmi ddimerandhba1clevelsfindingsincovid19iraqipatients |
| _version_ |
1756472392143601664 |